Evidence map›Paper›PMID 26392705›Full record

ReviewPharmacognosy reviews

An updated review of Terminalia catappa.

Arumugam Vijaya Anand, Natarajan Divya, Pannerselvam Punniya Kotti

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pharmacognosy reviews. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Tropical Almond Tree (Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  2. Phytochemical Evaluation ofInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Tropical almond (Heliyon · 2025
    Review
  7. Article
  8. Article
  9. Validation of Active Compound ofJournal of microbiology and biotechnology · 2024
    Article
  10. Slow pyrolysis ofBiochemistry and biophysics reports · 2024
    Article
  11. Article
  12. Identification of Phytochemicals and Assessment of Hypoglycemic and Haematological Potentials ofCardiovascular & hematological agents in medicinal chemistry · 2024
    Article
  13. Indian Almond (Antioxidants (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Cuticular Waxes and Cutin inMolecules (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Frontiers in pharmacology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arumugam Vijaya AnandDepartment of Science and Humanities, MIET Engineering College, Tiruchirappalli, India.
Natarajan DivyaDepartment of Biochemistry, MIET Engineering College, Tiruchirappalli, India.
Pannerselvam Punniya KottiDepartment of Biochemistry, Kanchi Shri Krishna College of Arts and Science, Kancheepuram, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Terminalia catappa Linn. is known for its nutritional fruit and possesses medicinal benefits as well. This is a comprehensive review of the phytoconstituents and pharmacological benefits. T. catappa has been recognized for its medicinally essential phytoconstituents, such as phenol, flavonoid, and carotenoid. Numerous pharmacological investigations have confirmed this plant's ability to exhibit antimicrobial, anti-inflammatory, antidiabetic, antioxidant, hepatoprotective, and anticancer activities, all of which support its traditional uses.

Indexed as

AnticancerantidiabeticantioxidanthepatoprotectiveTerminalia catappa

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.